Company Overview and News

Will Slow GDP Growth Take a Beating on Australia ETFs?

2018-03-12 zacks
Australia’s GDP grew slower than expected by economists, as bad weather led to a fall in exports. Construction activity further dragged down the GDP growth, weighing on gains provided by strong household activity.
Upvote Downvote

ASX reporting season shows Australian profits are up, but still lagging the world

With the Australian February reporting season now about 90 per cent complete, the ABC business desk feels its can make the big call: "It has been OK."
Upvote Downvote

TABCORP Holdings Limited 2018 Q2 - Results - Earnings Call Slides

2018-02-10 seekingalpha
The following slide deck was published by TABCORP Holdings Limited in conjunction with their 2018 Q2 earnings call.
Upvote Downvote

Commonwealth Bank Laundering Scandal Ends Run of Record Profits - Bloomberg

2018-02-06 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
Upvote Downvote

Cedar Fair Tops Consumer Cyclical Sector For January Despite Thin Broker Coverage

2018-01-23 seekingalpha
Cedar Fair led Corus Entertainment, Connect Group, and ITV plc as net gain Consumer Cyclical sector favorites per analyst thin target-price estimates calculated 1/19/18.
Upvote Downvote

Salem Leads Consumer Cyclical Sector Top Gain Stocks For December Per Broker Targets

2017-12-26 seekingalpha
Salem Media led Corus Entertainment, GWA Group, and Gamehost as net gain Consumer Cyclical sector favorites per analyst target-price estimates calculated 12/22/17.
Upvote Downvote

Deals of the day-Mergers and acquisitions

2017-12-12 reuters
Dec 12 (Reuters) - The following bids, mergers, acquisitions and disposals were reported by 1400 GMT on Tuesday:
Upvote Downvote

Deals of the day-Mergers and acquisitions

2017-12-01 reuters
Dec 1 (Reuters) - The following bids, mergers, acquisitions and disposals were reported by 1100 GMT on Friday:
Upvote Downvote

Libbey Leads Consumer Cyclical Sector Top Gain Stocks For November

2017-11-20 seekingalpha
Libbey led AMC Entertainment, B&N, National CineMedia and Gamestop as net gain Consumer Cyclical sector favorites by analyst target-price estimates calculated 11/16/17.
Upvote Downvote

Australia court delays US$6.9b merger of gambling giants

2017-09-20 themalaymailonline
The mega-merger has been referred back to the tribunal by the courts, putting the deal in doubt.— AFP pSYDNEY, Sept 20 — An Australian court today dealt a blow to a planned A$8.6 billion (RM29 billion) merger of gambling giants Tabcorp and Tatts, ordering a review of the deal following competition concerns.
Upvote Downvote

Australia court upholds appeal against Tabcorp's $4.9 bln buyout of Tatts

2017-09-20 reuters
SYDNEY (Reuters) - An Australian court upheld on Wednesday an appeal against betting firm Tabcorp Holdings Ltd’s (TAH.AX) agreed A$6.15 billion ($4.9 billion) buyout of lotteries operator Tatts Group Ltd (TTS.AX).
Upvote Downvote

Tabcorp and Tatts hold hands into halt pending judicial review

Tabcorp Holdings Ltd (ASX:TAH) and Tatts Group Ltd (ASX:TTS) have both been granted ASX trading halt in afternoon trade.
Upvote Downvote

Consumer Cyclical Top Dog Gainer Libbey Surpasses National CineMedia In September

2017-09-14 seekingalpha
Libby Glass blew past National CineMedia as target price and net gain Consumer Cyclical dog favorite by analyst-estimates calculated 9/8/17.
Upvote Downvote

Commonwealth Bank blames 'coding error' for alleged money-laundering breaches | Reuters

2017-08-07 reuters
SYDNEY (Reuters) - The Commonwealth Bank of Australia (CBA) on Monday said a software error was behind most of the roughly 53,700 times it allegedly broke anti-money laundering law, in a case that could see the country's biggest lender fined several billion dollars.
Upvote Downvote

Consumer Cyclical Dog Yield & Gains Paced By National CineMedia In August

2017-08-07 seekingalpha
National CineMedia led the July/August Consumer Cyclical dogs by analyst estimated net gains, price upside, and dividend yield, as calculated 8/1/17.
Upvote Downvote

Related Articles

RDHL: Redhill Biopharma Ltd (OTC:REDIF) Analysis and Research Report

2018-04-18 - Asif

History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...

SCYX: SCYNEXIS Analysis and Research Report

2018-04-16 - Asif

Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...

ENRT: Enertopia Corp (CNSX:TOP) Analysis and Research Report

2018-04-16 - Asif

Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...

FB: Facebook Analysis and Research Report

2018-04-15 - Asif

Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...

VSTM: Verastem Analysis and Research Report

2018-04-12 - Asif

Business Overview Verastem is a biopharmaceutical company focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients. The company's most advanced product candidates, duvelisib and defactinib, utilize a multi-faceted approach to treat cancers originating either in the blood or major organ systems. Verastem is currently evaluating these compounds in both preclinical and clinical studies as potential therapies for certain cancers, including leukemia, lymphoma, lung cancer, ovarian cancer, mesothelioma, and pancreatic cancer. The company believe that these compounds may be beneficial as therapeutics either as single agents or when used in combination with immuno-oncology agents or other current and emerging standard of care treatments in aggressive cancers that are poorly served by currently available therapies. Duvelisib targets the Phosphoinositide 3-kinase (PI3K) signaling pathway. The PI3K signaling pathway plays a centr...